Randomized Controlled Trial of Laparoscopic Gastric Bypass Plus Omentectomy Versus Laparoscopic Gastric Bypass Alone in Improving Diabetic Indices - Full Text View

Randomized Controlled Trial of Laparoscopic Gastric Bypass Plus Omentectomy Versus Laparoscopic Gastric Bypass Alone in Improving Diabetic Indices

This study is currently recruiting participants.
Verified by Legacy Health System, November 2007

Sponsored by:	Legacy Health System
Information provided by:	Legacy Health System
ClinicalTrials.gov Identifier:	NCT00552942

Purpose

To see if removing the omentum in addition to a gastric bypass improves diabetes is better than just a gastric bypass.

Condition	Intervention	Phase
Diabetes Interleukins Cytokines	Procedure: laparoscopic gastric bypass plus omentectomy	Phase III

MedlinePlus related topics:

Diabetes Weight Control

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Treatment, Randomized, Single Blind (Subject), Placebo Control, Parallel Assignment, Efficacy Study

Official Title:	Randomized Controlled Trial of Laparoscopic Gastric Bypass Plus Omentectomy Versus Laparoscopic Gastric Bypass Alone in Improving Diabetic Indices

Further study details as provided by Legacy Health System:

Primary Outcome Measures:

diabetic indices [ Time Frame: 6 months ]

Secondary Outcome Measures:

interleukin and cytokine levels, weight loss [ Time Frame: 6 months ]

Estimated Enrollment:	40
Study Start Date:	July 2006
Estimated Study Completion Date:	July 2008

Arms	Assigned Interventions
1: Experimental surgery plus omentectomy	Procedure: laparoscopic gastric bypass plus omentectomy
2: No Intervention standard gastric bypass

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

undergoing laparoscopic gastric bypass, >18 yo, understands english

Exclusion Criteria:

previous lower pelvic surgery, self-pay patients, previous weight loss surgery,

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00552942

Contacts


Contact: Dennis Hong, MD, MS.c, FRCSC	503-227-5050	dennishong70@gmail.com

Locations


United States, Oregon
	Oregon Weight Loss Surgery LLC	Recruiting
	Portland, Oregon, United States, 97210
	Contact: Dennis Hong, MD, MS.,c, FRCSC 503-227-5050 dennishong70@gmail.com

Sponsors and Collaborators

Legacy Health System

Investigators


Principal Investigator:	Dennis Hong, MD., MS.c, FRCSC	Oregon Weight Loss Surgery LLC

More Information

Study ID Numbers:	1234
First Received:	November 1, 2007
Last Updated:	November 1, 2007
ClinicalTrials.gov Identifier:	NCT00552942
Health Authority:	United States: Institutional Review Board

Keywords provided by Legacy Health System:

obesity

diabetes

cytokines

Study placed in the following topic categories:

Obesity

Diabetes Mellitus

ClinicalTrials.gov processed this record on August 29, 2008